GlobeNewswire

SolarWinds Delivers Unprecedented Visibility for Managing Cisco ASA Next-Generation Firewalls

Dela

SolarWinds Network Insight for Cisco ASA is now available as part of the latest versions of SolarWinds Network Performance Monitor and SolarWinds Network Configuration Manager

CORK, Ireland, Sept. 14, 2017 (GLOBE NEWSWIRE) -- SolarWinds, the worldwide leader in network management software, today announced SolarWinds® Network Insight(TM) for Cisco® Adaptive Security Appliances (ASA). SolarWinds Network Insight for Cisco ASA provides comprehensive monitoring-well beyond hardware health and performance-and the ability to manage access control lists (ACLs). Having the ability to see into the performance of next-generation firewalls is essential to successfully managing a hybrid IT environment. SolarWinds Network Insight for Cisco ASA is available in the latest versions of SolarWinds Network Performance Monitor and SolarWinds Network Configuration Manager, both part of the SolarWinds Orion® Platform.

"Devices like Cisco's Adaptive Security Appliance have complex states that cannot be understood simply by looking at tables of statistics," said Christoph Pfister, executive vice president of products, SolarWinds. "Leveraging SolarWinds' deep knowledge of networking for hybrid IT environments, we've created Network Insight for Cisco ASA to visualise the critical functions of this device and make it easier to resolve problems and mitigate threats quickly. Network Insight for Cisco ASA empowers IT pros to deliver secure and reliable connectivity for their business."

"Our ability to troubleshoot IPsec using the new ASA features in NPM 12.2 has given us visibility into metrics for both remote and site-to-site VPN metrics, which have traditionally only been monitored through three or four disparate tools that were difficult to manage, or lacked historical data collection and correlation," said Nick Zourdos, network administrator and NPM 12.2 beta user. "Not only has this already shown us how we can directly impact the delivery of key business services, but NPM 12.2 has given the team a whole new monitoring experience and appreciation for that aspect of the job."

SolarWinds Network Insight for Cisco ASA

In modern hybrid IT environments, firewalls provide critical connectivity to cloud-based assets.  Standard monitoring tools do not provide the needed visibility into key firewall metrics such as VPN tunnel connectivity and failover status and availability. SolarWinds Network Insight for Cisco ASA goes beyond basic up/down and provides network administrators with:

  • Visibility into, and reporting and alerting for:
    • VPN tunnel visibility (LAN-to-LAN)
    • High availability and failover status
    • Hardware status
    • Interface monitoring with critical configuration data such as security level
    • Connection count
  • ACL Monitoring:
    • Filter, search, and view ACLs with the firewall rule browser
    • Show relationships with ACLs, context, and objects
    • Snapshot, version, compare, and backup ACL configs
    • Analyse ACL configs and highlight shadowed, redundant, and unused rules

In addition to SolarWinds Network Insight for Cisco ASA, SolarWinds Network Performance Monitor and Network Configuration Manager also include support for F5® BIG-IP®environments with SolarWinds Network Insight for F5 BIG-IP. Support for additional appliances is expected in future releases.

Also New in SolarWinds Network Performance Monitor

  • PerfStack(TM) improvements, including real-time polling for key metrics and support for additional metrics such as Syslog, UnDP, SNMP traps, and more
  • Support for high availability (HA) multi-subnet deployments and disaster recovery

Pricing and Availability

Pricing for SolarWinds Network Performance Monitor starts at £2,195. Pricing for SolarWinds Network Configuration Manager starts at £2,160*. Pricing includes the first year of maintenance. For more information on SolarWinds IT management products, including downloadable, free 30-day evaluations, visit the SolarWinds website or call +353 21 500 2900.

*Prices as of September 13, 2017. Pricing may vary based upon the jurisdiction and applicable currency. Please contact a local SolarWinds sales representative to find pricing specific to your jurisdiction.

Additional Resources

Connect with SolarWinds

About the SolarWinds Orion Platform
The Orion platform is a modular and scalable unified monitoring platform. It allows IT departments to add modules as their needs grow, providing ever richer visibility into their environments. While these modules are sold as individual products, they run on a unified platform, with a single web-based dashboard, centralised management and access control, unified alerting and reporting, and consolidated metrics and data, which enables context-rich dashboards that centralise data from multiple parts of the stack into an application-centric view. The SolarWinds Orion Platform is trusted by 425 of the Fortune 500® companies to monitor, visualise, and analyse the performance of networks, applications, systems, and databases on-premises, in a hybrid environment, or in the cloud.

About SolarWinds

SolarWinds provides powerful and affordable IT management software to customers worldwide, from Fortune 500 enterprises to small businesses, managed service providers (MSPs), government agencies, and educational institutions. We are committed to focusing exclusively on IT, MSP, and DevOps professionals, and strive to eliminate the complexity that our customers have been forced to accept from traditional enterprise software vendors. Regardless of where the IT asset or user sits, SolarWinds delivers products that are easy to find, buy, use, maintain, and scale, while providing the power to address key areas of the infrastructure from on-premises to the cloud. This focus and commitment to excellence in end-to-end hybrid IT performance management has established SolarWinds as the worldwide leader in both network management software and MSP solutions, and is driving similar growth across the full spectrum of IT management software. Our solutions are rooted in our deep connection to our user base, which interacts in our THWACK online community to solve problems, share technology and best practices, and directly participate in our product development process. Learn more today at www.solarwinds.com.

The SolarWinds, SolarWinds & Design, Orion, and THWACK trademarks are the exclusive property of SolarWinds Worldwide, LLC or its affiliates, are registered with the U.S. Patent and Trademark Office, and may be registered or pending registration in other countries. All other SolarWinds trademarks, service marks, and logos may be common law marks or are registered or pending registration. All other trademarks mentioned herein are used for identification purposes only and are trademarks of (and may be registered trademarks of) their respective companies.

© 2017 SolarWinds Worldwide, LLC.  All rights reserved. 

       
MEDIA CONTACTS:      
Danielle Killick     Katherine O'Keeffe 
Text100     SolarWinds
Phone: 07974161187     Phone: +353 21 500 2954
LondonSolarWinds@text100.com     pr@solarwinds.com 




This announcement is distributed by Nasdaq Corporate Solutions on behalf of Nasdaq Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: SolarWinds Worldwide, LLC via Globenewswire

Om

GlobeNewswire



Följ GlobeNewswire

Abonnera på våra pressmeddelanden.

Senaste pressmeddelandena från GlobeNewswire

Karolinska Development's portfolio company Modus Therapeutics completes enrollment in Phase II study with sevuparin7.1.2019 12:00Pressmeddelande

STOCKHOLM, January 7, 2019. Karolinska Development's portfolio company Modus Therapeutics announces that the patient enrollment has been completed in the Phase II study with sevuparin in patients with sickle cell disease (SCD). The results from the study is expected in mid 2019. Modus Therapeutic's randomized, double blind study contains 140 SCD-patients with Acute Vaso Occlusive Crisis (VOC). It compares intravenously administered sevuparin with placebo. The primary endpoint of the study is the demonstration of a reduced time to resolution of patient's VOC. Clincal sites across Europe and the Middle East took part in the study that was conducted in conjunction with Modus Therapeutics' co development partner Ergomed. SCD has a high unmet medical need as there are currently no approved therapies for VOCs. It is an inherited blood disorder that affects between 90,000 to 100,000 patients in the U.S. and is characterized by severely painful VOCs that lead to organ damage due to a lack of o

Karolinska Development's portfolio company Modus Therapeutics completes enrollment in Phase II study with sevuparin7.1.2019 12:00Pressmeddelande

STOCKHOLM, January 7, 2019. Karolinska Development's portfolio company Modus Therapeutics announces that the patient enrollment has been completed in the Phase II study with sevuparin in patients with sickle cell disease (SCD). The results from the study is expected in mid 2019. Modus Therapeutic's randomized, double blind study contains 140 SCD-patients with Acute Vaso Occlusive Crisis (VOC). It compares intravenously administered sevuparin with placebo. The primary endpoint of the study is the demonstration of a reduced time to resolution of patient's VOC. Clincal sites across Europe and the Middle East took part in the study that was conducted in conjunction with Modus Therapeutics' co development partner Ergomed. SCD has a high unmet medical need as there are currently no approved therapies for VOCs. It is an inherited blood disorder that affects between 90,000 to 100,000 patients in the U.S. and is characterized by severely painful VOCs that lead to organ damage due to a lack of o

Stillfront Group rekryterar ansvarig för M&A19.12.2018 12:07Pressmeddelande

PRESSMEDDELANDE 19 december, 2018 Stillfront Group rekryterar ansvarig för M&A Stillfront Group, en marknadsledare inom 'free to play' online strategispel, annonserar idag att Marina Andersson har utsetts till ansvarig för M&A och kommer att ingå i koncernledningen. Marina har närmare tjugo års erfarenhet från investment banking och M&A. Hon har omfattande erfarenhet inom strategisk och finansiell rådgivning, affärsgenerering, projektledning inom förvärv och försäljningar av företag, finansiell analys, due diligence, samt företagsvärdering. Tidigare positioner inkluderar: Director, Deloitte's Corporate Finance Advisory team, Director, ICECAPITAL Securities, Associate Partner och Investment Manager, Deseven, samt M&A Analytiker på Carnegie. Marina har två magister-examen från Stockholms universitet och Russian Herzen State Pedagogical University. "Förvärv är en viktig del av Stillfronts affärsstrategi och vi är mycket glada att rekrytera Marina Andersson. Marinas breda erfarenhet och pr

Stillfront Group announces Head of M&A19.12.2018 12:07Pressmeddelande

PRESS RELEASE December 19, 2018 Stillfront Group announces Head of M&A Stillfront Group, a market leader in 'free to play' online strategy games, today announces that Marina Andersson has been appointed as Head of M&A and will be part of the Group's management team. Marina has close to 20 years track record of investment banking and M&A. She has extensive competence within strategic and financial advisory, deal generation, buy and sell side M&A project management, financial analysis, due diligence and company valuation. Former positions include: Director at Deloitte's Corporate Finance Advisory team, Director at ICECAPITAL Securities, Associate Partner and Investment Manager at Deseven, M&A Analyst at Carnegie. She holds two Master degrees from Stockholm University and Russian Herzen State Pedagogical University. "Acquisitions are a crucial part of Stillfront's business strategy and we are very pleased with the appointment of Marina Andersson. Marina's breadth of experience and profess

Oboya tecknar ett samarbetsavtal med Gaia avseende biomaterial13.12.2018 11:41Pressmeddelande

Oboya Horticulture Industries AB (publ) ("Oboya") har tecknat ett viktigt och långsiktigt samarbetsavtal avseende miljövänligt biomaterial med Gaia Biomaterials AB ("Gaia") i Helsingborg, Sverige. Avtalet innebär att Oboya använder Gaias biomaterial för tillverkning och utveckling av miljövänliga odlingsprodukter till odlingsindustrin. Oboya har under de senaste åren arbetat aktivt med innovation, miljö- och hållbarhetsfrågor och vårt mål är att främja miljö och hållbarhet inom odlingsindustrin genom att erbjuda miljövänliga odlingsprodukter till våra kunder. Oboya anser att användningen av biomaterial kommer att vara viktigt för framgång i omställningen till en fossilfri odlingsindustri världen över. Samarbetsavtalet innebär att Oboya använder Gaias biomaterial i sin produktion och att vi genom Gaias kompetens kan utveckla nya miljövänliga odlingsprodukter. Gaias biomaterial är biologiskt nedbrytbart, komposterbart samt ger upp till 80 % lägre koldioxidutsläpp vid förbränning jämfört

Oboya signs a cooperation agreement with Gaia regarding biomaterials13.12.2018 11:41Pressmeddelande

Oboya Horticulture Industries AB (publ) ("Oboya") has signed an important and long-term cooperation agreement on environmentally friendly biomaterials with Gaia Biomaterials AB ("Gaia") in Helsingborg, Sweden. The agreement means that Oboya uses Gaias biomaterials for the production and development of environmentally friendly cultivation products for the cultivation industry. Oboya has been actively involved in innovation, environmental and sustainability issues in recent years, and our goal is to encourage environmental and sustainability in the cultivation industry by offering environmentally friendly cultivation products to our customers. Oboya believes that the use of biomaterials will be important for success in the conversion to a fossil-free cultivation industry worldwide. The cooperation agreement means that Oboya uses Gaias biomaterials in its production and that through Gaias expertise we can develop new environmentally friendly cultivation products. Gaias biomaterials are bi

I vårt pressrum kan du läsa de senaste pressmeddelandena, få tillgång till pressmaterial och hitta kontaktinformation.

Besök vårt pressrum